Innovation Work as Play and Systematic Risk-Taking

Alexander Styhre
Additional contact information
Alexander Styhre: Chalmers University of Technology

Chapter 5 in Science-Based Innovation, 2008, pp 131-158 from Palgrave Macmillan

Abstract: Abstract One of the standing concerns in the pharmaceutical industry is that major pharmaceutical companies are dedicating substantial time and resources to develop so called “me-too” drugs, that is, drugs that are modelled on a competitor’s successful drug but sufficiently different to be patented (Busfield, 2006: 302). Busfield writes: “A study of approval by the US Food and Drug Administration (FDA) between 1989 and 2000 showed that approvals for new drugs consisted of relatively small proportion of all approvals, with only 35 of applications related to new chemical entities”. Expressed differently, there is a concern in the industry and in society that pharmaceutical firms are primarily interested in short-term profits rather than developing more sustainable product portfolios (Angell, 2004). What is of great importance here is the willingness to expose oneself to risks in the pharmaceutical industry.

Keywords: Synthesis Chemist; Major Pharmaceutical Company; Innovation Work; Laboratory Researcher; Time Pressure Condition (search for similar items in EconPapers)
Date: 2008
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-58251-4_5

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230582514

DOI: 10.1057/9780230582514_5

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().